BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38285918)

  • 1. Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study.
    Choi B; Liu GY; Sheng Q; Amancherla K; Perry A; Huang X; San José Estépar R; Ash SY; Guan W; Jacobs DR; Martinez FJ; Rosas IO; Bowler RP; Kropski JA; Banovich NE; Khan SS; San José Estépar R; Shah R; Thyagarajan B; Kalhan R; Washko GR
    Am J Respir Crit Care Med; 2024 May; 209(9):1091-1100. PubMed ID: 38285918
    [No Abstract]   [Full Text] [Related]  

  • 2. The Proteomic Profile of Interstitial Lung Abnormalities.
    Axelsson GT; Gudmundsson G; Pratte KA; Aspelund T; Putman RK; Sanders JL; Gudmundsson EF; Hatabu H; Gudmundsdottir V; Gudjonsson A; Hino T; Hida T; Hobbs BD; Cho MH; Silverman EK; Bowler RP; Launer LJ; Jennings LL; Hunninghake GM; Emilsson V; Gudnason V
    Am J Respir Crit Care Med; 2022 Aug; 206(3):337-346. PubMed ID: 35438610
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.
    Miller ER; Putman RK; Diaz AA; Xu H; San José Estépar R; Araki T; Nishino M; Poli de Frías S; Hida T; Ross J; Coxson H; Dupuis J; O'Connor GT; Silverman EK; Rosas IO; Hatabu H; Washko G; Hunninghake GM
    Ann Am Thorac Soc; 2019 Apr; 16(4):447-454. PubMed ID: 30543456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers.
    Choi B; San José Estépar R; Godbole S; Curtis JL; Wang JM; San José Estépar R; Rosas IO; Mayers JR; Hobbs BD; Hersh CP; Ash SY; Han MK; Bowler RP; Stringer KA; Washko GR; Labaki WW
    Respir Res; 2023 Nov; 24(1):265. PubMed ID: 37925418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omics and the Search for Blood Biomarkers in Chronic Obstructive Pulmonary Disease. Insights from COPDGene.
    Regan EA; Hersh CP; Castaldi PJ; DeMeo DL; Silverman EK; Crapo JD; Bowler RP
    Am J Respir Cell Mol Biol; 2019 Aug; 61(2):143-149. PubMed ID: 30874442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-based Transcriptomic and Proteomic Biomarkers of Emphysema.
    Suryadevara R; Gregory A; Lu R; Xu Z; Masoomi A; Lutz SM; Berman S; Yun JH; Saferali A; Ryu MH; Moll M; Sin DD; Hersh CP; Silverman EK; Dy J; Pratte KA; Bowler RP; Castaldi PJ; Boueiz A;
    Am J Respir Crit Care Med; 2024 Feb; 209(3):273-287. PubMed ID: 37917913
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of visual and quantitative methods to identify interstitial lung abnormalities.
    Kliment CR; Araki T; Doyle TJ; Gao W; Dupuis J; Latourelle JC; Zazueta OE; Fernandez IE; Nishino M; Okajima Y; Ross JC; Estépar RS; Diaz AA; Lederer DJ; Schwartz DA; Silverman EK; Rosas IO; Washko GR; O'Connor GT; Hatabu H; Hunninghake GM
    BMC Pulm Med; 2015 Oct; 15():134. PubMed ID: 26514822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of peripheral protein biomarkers for the prediction of incident interstitial features: a multicentre retrospective cohort study.
    Ash S; Doyle TJ; Choi B; San Jose Estepar R; Castro V; Enzer N; Kalhan R; Liu G; Bowler R; Wilson DO; San Jose Estepar R; Rosas IO; Washko GR
    BMJ Open Respir Res; 2024 Mar; 11(1):. PubMed ID: 38485250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.
    Parulekar AD; Martinez C; Tsai CL; Locantore N; Atik M; Yohannes AM; Kao CC; Al-Azzawi H; Mohsin A; Wise RA; Foreman MG; Demeo DL; Regan EA; Make BJ; Boriek AM; Wiener LE; Hanania NA
    J Am Med Dir Assoc; 2017 Dec; 18(12):1063-1068. PubMed ID: 29169736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suspected Interstitial Lung Disease in COPDGene Study.
    Rose JA; Menon AA; Hino T; Hata A; Nishino M; Lynch DA; Rosas IO; El-Chemaly S; Raby BA; Ash SY; Choi B; Washko GR; Silverman EK; Cho MH; Hatabu H; Putman RK; Hunninghake GM
    Am J Respir Crit Care Med; 2023 Jan; 207(1):60-68. PubMed ID: 35930450
    [No Abstract]   [Full Text] [Related]  

  • 11. The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes.
    Carolan BJ; Hughes G; Morrow J; Hersh CP; O'Neal WK; Rennard S; Pillai SG; Belloni P; Cockayne DA; Comellas AP; Han M; Zemans RL; Kechris K; Bowler RP
    Respir Res; 2014 Oct; 15(1):127. PubMed ID: 25306249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging Advances in Chronic Obstructive Pulmonary Disease. Insights from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) Study.
    Bhatt SP; Washko GR; Hoffman EA; Newell JD; Bodduluri S; Diaz AA; Galban CJ; Silverman EK; San José Estépar R; Lynch DA
    Am J Respir Crit Care Med; 2019 Feb; 199(3):286-301. PubMed ID: 30304637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Interstitial Lung Abnormalities and All-Cause Mortality.
    Putman RK; Hatabu H; Araki T; Gudmundsson G; Gao W; Nishino M; Okajima Y; Dupuis J; Latourelle JC; Cho MH; El-Chemaly S; Coxson HO; Celli BR; Fernandez IE; Zazueta OE; Ross JC; Harmouche R; Estépar RS; Diaz AA; Sigurdsson S; Gudmundsson EF; Eiríksdottír G; Aspelund T; Budoff MJ; Kinney GL; Hokanson JE; Williams MC; Murchison JT; MacNee W; Hoffmann U; O'Donnell CJ; Launer LJ; Harrris TB; Gudnason V; Silverman EK; O'Connor GT; Washko GR; Rosas IO; Hunninghake GM; ;
    JAMA; 2016 Feb; 315(7):672-81. PubMed ID: 26881370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
    Serban KA; Pratte KA; Strange C; Sandhaus RA; Turner AM; Beiko T; Spittle DA; Maier L; Hamzeh N; Silverman EK; Hobbs BD; Hersh CP; DeMeo DL; Cho MH; Bowler RP
    EBioMedicine; 2022 Oct; 84():104262. PubMed ID: 36155958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts.
    Choi B; Adan N; Doyle TJ; San José Estépar R; Harmouche R; Humphries SM; Moll M; Cho MH; Putman RK; Hunninghake GM; Kalhan R; Liu GY; Diaz AA; Mason SE; Rahaghi FN; Pistenmaa CL; Enzer N; Poynton C; Sánchez-Ferrero GV; Ross JC; Lynch DA; Martinez FJ; Han MK; Bowler RP; Wilson DO; Rosas IO; Washko GR; San José Estépar R; Ash SY;
    Chest; 2023 Jan; 163(1):164-175. PubMed ID: 35780812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
    Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
    Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort.
    Ash SY; Harmouche R; Ross JC; Diaz AA; Rahaghi FN; Vegas Sanchez-Ferrero G; Putman RK; Hunninghake GM; Onieva Onieva J; Martinez FJ; Choi AM; Bowler RP; Lynch DA; Hatabu H; Bhatt SP; Dransfield MT; Wells JM; Rosas IO; San Jose Estepar R; Washko GR;
    Radiology; 2018 Aug; 288(2):600-609. PubMed ID: 29869957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts.
    Ash SY; San José Estépar R; Fain SB; Tal-Singer R; Stockley RA; Nordenmark LH; Rennard S; Han MK; Merrill D; Humphries SM; Diaz AA; Mason SE; Rahaghi FN; Pistenmaa CL; Sciurba FC; Vegas-Sánchez-Ferrero G; Lynch DA; Washko GR;
    Radiology; 2021 Apr; 299(1):222-231. PubMed ID: 33591891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between occupational exposure and lung function, respiratory symptoms, and high-resolution computed tomography imaging in COPDGene.
    Marchetti N; Garshick E; Kinney GL; McKenzie A; Stinson D; Lutz SM; Lynch DA; Criner GJ; Silverman EK; Crapo JD;
    Am J Respir Crit Care Med; 2014 Oct; 190(7):756-62. PubMed ID: 25133327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls.
    Lutz SM; Frederiksen B; Begum F; McDonald MN; Cho MH; Hobbs BD; Parker MM; DeMeo DL; Hersh CP; Ehringer MA; Young K; Jiang L; Foreman MG; Kinney GL; Make BJ; Lomas DA; Bakke P; Gulsvik A; Crapo JD; Silverman EK; Beaty TH; Hokanson JE;
    Nicotine Tob Res; 2019 May; 21(6):714-722. PubMed ID: 29767774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.